Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer

Cited by (178)

Items 101–178 of 178

1. Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
   Jae Cheol Lee, Seung Hun Jang, Kye Young Lee, Young‐Chul Kim · 2013 · Cancer Research and Treatment
2. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo
   Ning Liu, Mingxing Ma, Na Qu, Ruizhe Wang, Hao Chen, Fangzhu Hu, Song Gao, Fengping Shan · 2020 · International Immunopharmacology
3. Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo
   Yuan Qing Qu, Linlin Song, Su Xu, Margaret Sum Yee Yu, Onat Kadioglu, Francesco Michelangeli, Betty Yuen Kwan Law, Thomas Efferth, Christopher Wai-Kei Lam, Vincent Kam Wai Wong · 2023 · Pharmacological Research
4. Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo
   YILI HAN, Yong Luo, Jiahui Zhao, Mingchuan Li, Yongguang Jiang · 2014 · Oncology Letters
5. Duchesnea indicaextract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition
   Pei‐Ni Chen, Shun‐Fa Yang, Cheng‐Chia Yu, Chin-Yin Lin, Shih‐Han Huang, Shu‐Chen Chu, Yih‐Shou Hsieh · 2017 · Environmental Toxicology
6. Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer
   Maryam Akbarzadeh, Shabnam Akbarzadeh, Maryam Majidinia · 2020 · Pathology - Research and Practice
7. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma
   Kian Ngiap Chua, Li Ren Kong, Wen Jing Sim, Hsien Chun Ng, Weijie Richard Ong, Jean Paul Thiery, Hung The Huynh, Boon Cher Goh · 2015 · Oncotarget
8. The inhibitory effect of anthocyanins on Akt on invasion and epithelial-mesenchymal transition is not associated with the anti-EGFR effect of the anthocyanins
   Jing Nan Lu, Won Sup Lee, MIN JEONG KIM, Jeong Won Yun, Ji Hyun Jung, Sang Mi Yi, Jae‐Hoon Jeong, Hye Jung Kim, Yung Hyun Choi, Gon-Sup Kim et al. · 2014 · International Journal of Oncology
9. Influence of the Twist gene on the invasion and metastasis of colon cancer
   Duowei Wang, Bikash Rai, Feng Qi, Tong Liu, Jinmiao Wang, Xiaodong Wang, Bozhao Ma · 2017 · Oncology Reports
10. Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cells
    Okan Tezcan, Ufuk Gündüz · 2014 · Biomedicine & Pharmacotherapy
11. Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment
    Hye-Ryoun Kim, Jae Chol Lee, Young‐Chul Kim, Kyu Sik Kim, In‐Jae Oh, Sung Yong Lee, Tae Won Jang, Min Ki Lee, Kyeong Cheol Shin, Gwan Ho Lee et al. · 2013 · Lung Cancer
12. Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
    Mário Šereš, Katarina Spacayova, Zdena Sulová, Jana Špaldová, Albert Breier, Lucia Pavlíková · 2025 · Cancers
13. Alteration of the E-cadherin/β-Catenin Complex Predicts Poor Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment
    Seol Bong Yoo, Yu Jung Kim, Hyojin Kim, Yan Jin, Ping-Li Sun, Sanghoon Jheon, Jong Seok Lee, Jin-Haeng Chung · 2013 · Annals of Surgical Oncology
14. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo
    Shu‐Chen Chu, Yih‐Shou Hsieh, Li‐Sung Hsu, Kuo-Shuen Chen, Chien-Cheng Chiang, Pei‐Ni Chen · 2013 · Integrative Cancer Therapies
15. Lysyl hydroxylases are transcription targets for GATA3 driving lung cancer cell metastasis
    Wei Liu, Ting Zhang, Lixia Guo, Yuanyuan Wang, Yanan Yang · 2018 · Scientific Reports
16. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells
    Masashi Kawami, Risako Harada, Takamichi Ojima, Yohei Yamagami, Ryoko Yumoto, Mikihisa Takano · 2019 · Toxicology
17. Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature
    Arkaprabha Basu, Manash Kumar Paul, Mitchel Alioscha‐Perez, Anna Grosberg, Hichem Sahli B, Steven M. Dubinett, Shimon Weiss · 2022 · Communications Biology
18. Patient-derived xenograft models for oncology drug discovery
    Gang Li · 2015 · Journal of Cancer Metastasis and Treatment
19. Long range personalized cancer treatment strategies incorporating evolutionary dynamics
    Chen‐Hsiang Yeang, Robert A. Beckman · 2016 · Biology Direct
20. Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance
    Mohammed Kaleem, Lubna Azmi, Naiyer Shahzad, Murtada Taha, Shiv Kumar, Md Ali Mujtaba, Abdulelah Y. Hazazi, Asaad Kayali · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
21. Dendrofalconerol A suppresses migrating cancer cells via EMT and integrin proteins.
    Premkamol Pengpaeng, Boonchoo Sritularak, Pithi Chanvorachote B · 2015 · PubMed
22. Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways
    Young Yun Jung, Arunachalam Chinnathambi, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Alan Prem Kumar, Gautam Sethi, Kwang Seok Ahn · 2022 · Journal of Cellular Biochemistry
23. Crizotinib attenuates cancer metastasis by inhibiting TGFβ signaling in non-small cell lung cancer cells
    Soonbum Park, Eun A Cho, Jung Nyeo Chun, Da Young Lee, Sanghoon Lee, Mi Yeon Kim, Sang Mun Bae, Su In Jo, So Hee Lee, Hyun Ho Park et al. · 2022 · Experimental & Molecular Medicine
24. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells
    Tsou Shang-Hsun, Ming-Hung Hou, Lih‐Ching Hsu, Tzer-Ming Chen, Yen‐Hui Chen · 2015 · International Journal of Molecular Medicine
25. Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers
    Leonardo Marques da Fonseca, Vanessa Amil da Silva, Kelli Monteiro da Costa, Jhenifer Santos dos Reis, Jose Osvaldo Previato, Lúcia Mendonça‐Previato, Leonardo Freire‐de‐Lima · 2022 · Glycoconjugate Journal
26. Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation
    Zhenhui Guo, Heng Yin, Tong Wu, Shaofeng Wu, Lingyun Liu, Lei Zhang, Yanli He, Ren Zhang, Na Liu · 2022 · Journal of Ethnopharmacology
27. ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway
    Lanlan Lin, Fan Yang, Dong-Huan Zhang, Cong Hu, Sheng Yang, Xiang-Qi Chen · 2021 · Cancer Cell International
28. Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets
    Laura J. Tafe · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
29. Resistance to Therapy
    Gabriel A. Rivera, Heather A. Wakelee · 2016 · Cancer treatment and research
30. Cytoplasm-localized SIRT1 downregulation attenuates apoptosis and cell cycle arrest in cisplatin-resistant lung cancer A549 cells
    Hyeran Yu, Youngmee Kim, Moonjae Cho · 2020 · Journal of Cancer
31. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells
    Young Yun Jung, Seung Ho Baek, Acharan Singh Narula, Ojas A. Namjoshi, Bruce E. Blough, Kwang Seok Ahn · 2021 · Life Sciences
32. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell
    Jian Zhang, Jianhong Zuo, Mingsheng Lei, Song Wu, Xiaofang Zang, Chaoyue Zhang · 2014 · Chinese Medical Journal
33. Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance
    Hao Gu, Xinyu Wu, Ruitai Fan, Xin Wang, You-Zhong Guo, Rui Wang · 2016 · Oncology Letters
34. Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells
    Zahirah Siti, A.M.I. Seoparjoo, H. Shahrul · 2019 · Heliyon
35. Integrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer
    Dalia M. Abd El‐Rehim, Manal Ismail Abd‐Elghany, Maiiada Nazmy · 2015 · Journal of the Egyptian National Cancer Institute
36. CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer
    Kaiyong Yang, Chunli Zhang, Zeyu Wang, Qiqing Huang, Jing Qian, Gaoyu Shi, Wenwen Sun, Jinqiu Wang, Ji Hoon Yu, Zhaorui Sun et al. · 2025 · ACS Applied Materials & Interfaces
37. The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior
    Veronika Skarková, Marketa Krupova, Barbora Vítovcová, Adam Skarka, Petra Kašparová, Petr Krůpa, Věra Králová, Emil Rudolf · 2019 · International Journal of Molecular Sciences
38. Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
    Adil Farooq Wali, Sirajunisa Talath, Rasha Babiker, Mohamed El‐Tanani, Imran Rashid Rangraze, Walaa Ibraheem, Yusra Al-Dhaheri, Shakta Mani Satyam, Yahia El‐Tanani · 2026 · Frontiers in Pharmacology
39. RGMb impacts partial epithelial‐mesenchymal transition and BMP2‐Induced ID mRNA expression independent of PD‐L2 in nonsmall cell lung cancer cells
    Sofie Rahbek Dorset, Tina Fuglsang Daugaard, Trine Vilsbøll Larsen, Anders Lade Nielsen · 2023 · Cell Biology International
40. The Impacts and Changes Related to the Cancer Drug Resistance Mechanism
    Prachi Varshney, Vishal Sharma, Devdhar Yadav, Yogesh Kumar, Amit Singh, Naga Rani Kagithala, Pramod Kumar Sharma, Omji Porwal, Neeraj Kumar Fuloria, Pradeep Kumar Sharma et al. · 2023 · Current Drug Metabolism
41. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells
    Xin Liu, Lili Ban, Gang Luo, Zhiyao Li, Yunfeng Li, Yongchun Zhou, Xicai Wang, Congguo Jin, Jia-Gui Ye, Ding-Ding Ma et al. · 2016 · Anti-Cancer Drugs
42. Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening
    Vivek Kaushik, Juan Sebastián Yakisich, Yogesh Kulkarni, Neelam Azad, Anand Krishnan V. Iyer · 2018 · InTech eBooks
43. SERPING1 Reduces Cell Migration via ERK ‐ MMP2 ‐ MMP ‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma
    Ching‐Chuan Hsieh, Yuh‐Harn Wu, Yili Chen, Chun‐I Wang, Chang-Qing Li, I‐Hsiu Liu, Chen‐Wei Chou, Yang-Hsiang Lin, Po‐Shuan Huang, Te‐Chia Huang et al. · 2024 · Environmental Toxicology
44. The actin cytoskeleton: Morphological changes in pre- and fully developed lung cancer
    Arkaprabha Basu, Manash Kumar Paul, Shimon Weiss · 2022 · Biophysics Reviews
45. Exploring the influence of microgravity on chemotherapeutic drug response in cancer: Unveiling new perspectives
    Preksha Manish Vora, Sudharshan Prabhu · 2024 · Journal of Cellular and Molecular Medicine
46. Effects of RECQ1 helicase silencing on non-small cell lung cancer cells
    Li Lin, Mingyang Gao, Bo Song, Hua Zhang, Yanfu Wang · 2016 · Biomedicine & Pharmacotherapy
47. Statins and adhesion molecules: a review of a novel pleiotropic property of statins
    Mahvash Sadeghi, Sajad Dehnavi, Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2025 · Immunologic Research
48. Chemotherapy Increases Aggressiveness of Prostate Cancer via Epithelial Mesenchymal Transition
    John J. Kim · 2013 · Cell Biology Research & Therapy
49. Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Byoung Soo Kwon, Ji Hyun Park, Woo Sung Kim, Joon Seon Song, Chang‐Min Choi, Jin Kyung Rho, Jae Cheol Lee · 2017 · Tuberculosis & respiratory diseases
50. SMAD signaling in cancer: integrative roles in tumor progression, immune evasion, and therapeutic resistance
    Hai Zhao, Fan Yang, Jiaxin Yang, Sheng Yang · 2025 · Cytokine
51. Epithelial-mesenchymal dynamics in cancer: Role of signalling pathways, stromal interactions and natural therapies
    Iram Rais Alam Khan, Anindita Behera, Kamesh R. Babu, Faisal Rehman, Farah Rehan, Shraddha Manish Gupta, Siddharth Singh · 2025 · ADMET & DMPK
52. Role of Cytomorphology in the Era of Liquid Biopsy
    Eduardo Clery, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone, Fernando Carlos Schmitt · 2019 · Acta Cytologica
53. Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway
    Tomoyo Yoshimori, Masashi Kawami, Yuta Kumagai, Sorahito Futatsugi, Ryoko Yumoto, Yasuo Uchida, Mikihisa Takano · 2024 · The International Journal of Biochemistry & Cell Biology
54. Analysis of Flora Distribution and Drug Resistance in Sputum Culture from Patients with Lung Cancer
    Hao Feng, Rui Ze, Xue Yan Wang, Hui Jing Xu, Fang Fang, Li Zhang, Hui Zheng, Yu Xuan Zang, Yan Li · 2013 · Advanced materials research
55. Fidelity and Stability of PDX Models
    Gang Li · 2017 · Molecular and translational medicine
56. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling
    Hardyanti Eka Putri, Boonchoo Sritularak, Pithi Chanvorachote B · 2021 · Anticancer Research
57. Generating drug resistance models in human and murine cancer cell lines and assessing cross-resistance to chemotherapeutics and KRAS inhibitors
    Nicole Martinez, Maria Fumagalli, Ravindra Gujar, Lev Becker, Chang Cui · 2026 · STAR Protocols
58. Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug
    Resistance de Castro, Paul Andrew Clarke, Bissan Al‐Lazikani, Paul Workman · 2013
59. Metastatic Spread of Lung Cancer to Brain and Liver
    David James Pinato, Francesco Angelo Mauri · 2014 · Elsevier eBooks
60. In vivo and in vitro cell based model of lung adenocarcinoma from patients with pleural effusion
    Mikuláš Popovič, Yiling Liu, Erika Lattová, Dean L. Mann, Sabrina Curreli, Zbyněk Zdráhal, Martin Joseph Edelman, Joseph Bryant · 2021 · Neoplasma
61. The role of the Homeobox gene HOXD10 in Lung and Head & Neck carcinoma
    Fahad Hakami · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
62. The role of epidermal growth factor receptor in non-small cell lung cancer Epidermal growth factor reseptorünün küçük hücreli olmayan akciğer kanserindeki rolü
    Feyda Nursal · 2015
63. Autophagy Regulation of the Tumor Immunity – An Old Machinery for a New Function
    Tsolère Arakelian, Takouhie Mgrditchian, Elodie Viry, Kris Van Moer, Guy Berchem, Salem Chouaı̈b, Bassam Janji · 2015 · InTech eBooks
64. Autophagy Activation in the Tumor Microenvironment
    Bassam Janji, Elodie Viry, Takouhie Mgrditchian, Tsolère Arakelian, Sandrine Medves, Guy Berchem · 2016 · Elsevier eBooks
65. Short Communication Cell Biology: Research & Therapy
    John J. Kim, James E. Verdone, Steven M. Mooney · 2013
66. Targets of Tumor Epigenetics and Its Microenvironment in Gastrointestinal Cancer
    Ssu-Yin Yen, Hong-Meng Chuang, Mao-Hsuan Huang, Sheng-Feng Tsai, Tzyy‐Wen Chiou, Hong‐Lin Su, Li‐Ing Ho, Shinn‐Zong Lin, Horng‐Jyh Harn · 2017 · WORLD SCIENTIFIC eBooks
67. Cubic and spherical nanoparticles for detection and therapy of cancer
    Dhananjay Suresh · 2016
68. Effect of HGF/c-Met pathway in oral squamous cell carcinoma on EMT and metastatic potential
    Kazutaka Kimura, Yuichi Ohnishi, Tomoharu Okamura, Kazuya Tominaga, Masahiro Nakajima · 2019 · Journal of Osaka Dental University
69. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway
    Peng YangGang, WangHongjun Huo, Qiang LiYan, ZhaoYuanhang Liu · 2015
70. Publications from Juntendo University Graduate School of Medicine, 2012 [3/6]
    2014 · Juntendō Igaku/Juntendo igaku
71. ผลยบยงของไซพรพดนตอการเปลยนแปลงจากเซลลเยอบผวไปเปนเซลลมเซนไคมในเซลลมะเรงปอดชนดไมใชเซลลเลกผานวถของเอเคท
    สุรัสวดี ตรีสุวรรณ, วริษา พงศ์เรขนานนท์ · 2017
72. 3,4-dihydroxy-5,4’-dimethoxybibenzyl sensitizes non-small cell lung cancer cells to cisplatin-induced apoptosis via p53 upregulation
    Hardyanti Eka Putri, Pithi Chanvorachote · 2021
73. [TRIM21 Inhibits the Proliferation and Migration of Lung Adenocarcinoma Cells by Interacting with ZSWIM1].
    Luxuan Chen, Qionghua Lian, Gui Zhang, Jiayao Wu, Guandi Zeng, Xuejuan Gao · 2024 · PubMed Central
74. Cathepsin B mediates HDAC inhibitor-induced epithelial-mesenchymal transition in lung cancer cells
    Xiaorui Wan, Huanchen Wu, Jie Xue, Haidong Xu, Jing Wang, Jiani Huang, Weilong Wu, Ruihan Zhang, Zhongqin Liang, Zhenyu Xuan et al. · 2026 · European Journal of Pharmacology
75. Mechanism of LPS-activated gingival fibroblasts promote the migration of gastric cancer cells via CXCL12/CXCR4-Snail2-EMT axis
    Tongbin Liu, Qi Tang, Min Liu, Fangping Ren, Rubing Liu · 2026 · In Vitro Cellular & Developmental Biology - Animal
76. Contrôle de la progression tumorale broncho-pulmonaire par FHIT : Implication du récepteur HER2
    Amina Jouida · 2017
77. Epithelial–Mesenchymal Plasticity in Cancer: Transcriptional Regulation, Biomarker Challenges, and Emerging Therapeutic Opportunities
    Dhrruv Shah, Rajasekhar Reddy Alavala · 2026 · Cell Biochemistry and Function
78. BindingDB Entry 50017929: Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer.
    BindingDB · 2023 · UC San Diego